Hyperpolarization-activated, Cyclic Nucleotide-gated Channels Related Drug Discovery Products
Membrane protein stable cell lines are widely used in many areas of biomedical research. Creative Biolabs can offer membrane protein stable cell lines to stablish in vitro models for High Throughput Screening.
Creative Biolabs offers high-quality, innovative tools to help research groups accelerate membrane protein drug discovery. They can be found by targets. If there is no product that meets your needs, please contact us.
Hyperpolarization-activated, cyclic nucleotide-gated (HCN) channels are a critical class of ion channels that play a crucial role in controlling the electrical properties of neurons and cardiac cells. These channels are responsible for setting the resting membrane potential and the input resistance of neurons, as well as contributing to the rhythmic electrical activity in the heart and the nervous system.
Creative Biolabs offers a range of hyperpolarization-activated, cyclic nucleotide-gated channel tools in a timely and cost-effective manner:
- Hyperpolarization-Activated, Cyclic Nucleotide-Gated Channel Assays
- Ion Channel Cell Lines
- Ion Channel Membranes
- Membrane Protein Tools
Overview of Hyperpolarization-activated, Cyclic Nucleotide-gated Channels
Comprising four members—HCN1 through HCN4—the HCN channel family exhibits both shared characteristics and distinct attributes that underpin their varied physiological functions. The following elucidates each member's unique properties within the HCN channel family:
HCN1: HCN1 is primarily expressed in the brain, particularly within the neocortex, hippocampus, and cerebellum. Boasting rapid activation kinetics, HCN1 channels regulate neuronal excitability, contribute to resting membrane potential maintenance, and play a pivotal role in synaptic integration and neuronal plasticity.
HCN2: HCN2 channels exhibit a more expansive expression pattern, spanning both the brain and heart. Present in the thalamus, hippocampus, and cerebellum of the nervous system and the sinoatrial (SA) node of the heart, these channels, possessing intermediate activation kinetics, regulate neuronal excitability, thalamic rhythmic activity, and heart rate.
HCN3: The most limited in expression among HCN channels, HCN3 is present in the brain, heart, and peripheral nervous system at relatively lower levels. With the slowest activation kinetics among family members, HCN3's specific physiological roles remain less delineated than those of HCN1 and HCN2; however, it is hypothesized to contribute to the modulation of neuronal and cardiac activity.
HCN4: Predominantly expressed in the heart, specifically the sinoatrial (SA) and atrioventricular (AV) nodes, HCN4 is indispensable for generating and regulating cardiac pacemaker activity. Exhibiting slow activation kinetics akin to HCN3, HCN4 is also present in the thalamus, hypothalamus, and brainstem, where it modulates neuronal excitability and rhythmic activity.
Hyperpolarization-activated, Cyclic Nucleotide-gated Channels Drug Discovery
Given the HCN channels' essential roles in various physiological processes, they have emerged as attractive targets for pharmacological intervention. The development of novel therapeutics aims to modulate the function of HCN channels in a controlled and isoform-specific manner to alleviate disease symptoms without inducing unwanted side effects.
Drug discovery efforts have primarily focused on the identification of small molecules capable of selectively modulating the activity of specific HCN isoforms. These pharmacological agents can be categorized as agonists or antagonists, depending on their ability to enhance or inhibit channel function, respectively.
The potential therapeutic applications of HCN channel modulators encompass a wide range of pathophysiological conditions, including cardiac arrhythmias, epilepsy, chronic pain, and depression. By selectively targeting the HCN isoforms implicated in these disorders, researchers hope to develop more effective and safer treatment options for patients.
In conclusion, HCN channels represent a promising avenue for drug discovery, with the potential to address various medical conditions characterized by abnormal cellular excitability. As our understanding of the molecular mechanisms governing HCN channel function continues to expand, the prospects for the development of innovative and targeted therapeutics will undoubtedly grow in tandem.
